Effects of gamma-aminobutyric acid on insulin, glucagon, and somatostatin release from isolated perfused dog pancreas

Endocrinology. 1983 Jul;113(1):111-3. doi: 10.1210/endo-113-1-111.

Abstract

The effects of gamma-aminobutyric acid (GABA) on the secretion of insulin, glucagon, and somatostatin were studied in the isolated dog pancreas. Insulin secretion was inhibited in a dose-related fashion for 10 min or more by as little as 1 microM GABA. A prompt but small and transitory rise in somatostatin secretion, lasting only 1 min, occurred at GABA concentrations of 10 and 100 microM, levels that exert inhibitory effects on nervous tissue. Bicuculline, a GABA antagonist, inhibited insulin secretion and did not antagonize GABA-mediated insulin inhibition. The results suggest that GABA in concentrations that are known to exist in islet tissue can influence the secretion of islet hormones.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Bicuculline / pharmacology
  • Dogs
  • Glucagon / metabolism*
  • Insulin / metabolism*
  • Male
  • Pancreas / drug effects
  • Pancreas / metabolism*
  • Perfusion
  • Somatostatin / metabolism*
  • Time Factors
  • gamma-Aminobutyric Acid / pharmacology*

Substances

  • Insulin
  • Somatostatin
  • gamma-Aminobutyric Acid
  • Glucagon
  • Bicuculline